Resistance mechanisms involve genetic mutations (e.g., MET exon 14 skipping mutations), epigenetic alterations, and tumor microenvironment adaptation changes (Bukowski et al., 2020), and new strategies are urgently needed to overcome these barriers. The gene discussed is MET; the disease is neoplasm.